New approaches to managing infections in cardiac and peripheral vascular surgery are
required to reduce costs to patients and healthcare providers. Bacteriophage (phage) …

There is considerable interest in the use of bacteriophages (phages) to treat Pseudomonas
aeruginosa infections associated with left ventricular assist devices (LVADs). These …

Left ventricular assist device-associated driveline infectio... : Current Opinion in Infectious
Diseases Left ventricular assist device-associated driveline infections as a specific form of …

We conducted a prospective open-labeled, clinical trial, with a two-by-two factorial design, of
argon cold plasma (ACP) application and two different types of driveline positioning for the …

Annually, more than 250,000 patients in the United States suffering from advanced heart
failure may potentially benefit from treatment with durable left ventricular assist device …

Abstract Purpose of Review To review the current literature on ventricular assist device
(VAD) infections, with emphasis on epidemiology, treatment, and post-transplant outcomes …

Background Patients with long-term ventricular assist devices (VAD) are predisposed to
infection, bleeding, and pressure injuries at the insertion of the driveline. There is no …

Background Hospital readmissions following left ventricular assist device (LVAD) remain a
frequent comorbidity, associated with decreased quality of life and increased resources …

Purpose To address the clinical need for totally implantable mechanical circulatory support
devices, Bionet Sonar is developing a novel Ultrasonic Transcutaneous Energy …

We conducted a prospective, open-labeled, clinical trial, with a two-by-two factorial design,
of argon cold plasma application and two different types of driveline positioning for the …